24/7 Wall St. » ALTU

The 52-Week Low Club (AFL)(ALTU)(PSUN)(KVA)

247wallst — Mon, 26 Jan 2009 15:58:46 +0000

AFLAC Incorporated (AFL) DeutscheBank dowgrades shares. Fall to $19.38 from 52-week high of $68.81.

Altus Pharmaceuticals (ALTU) Sharp job cuts. Drops to $.23 from 52-week high of $6.66.

Pacific Sunwear of California (PSUN) No obvious news, just selling. Down to $.72 from 52-week high of $14.04.

K-V Pharmaceutical (KVA) May default on credit lines. Sells off to $.49 from 52-week high of $28.25.

Douglas A. McIntyre

Posted in HI/LOW Tagged: AFL, ALTU, KVA, PSUN

52-Week Low Club (ALTU, SIL, CEG, COMV, EIX, ZINC, MIR, ZOLT)

247wallst — Tue, 12 Aug 2008 15:09:56 +0000

Over the last three days it has been thin for 52-week lows, but a good market drop sure brings a reminder to the wall of shame. Here are some of today’s key 52-week lows.

Altus Pharmaceuticals (NASDAQ: ALTU) tanked after Phase III cystic fibrosis tests failed to please on all fronts.
Apex Silver Mines (AMEX: SIL) fell nearly 40% after earnings disappointed. At least they can use those mines for mushroom growth if they don’t find silver.

Constellation Energy (NYSE: CEG) Fell over $11.00 to new 52-week lows after an analyst raised more questions about the company.
Comverge (NASDAQ: COMV) fell on its sword after missing estimates and lowering targets on regulatory changes at a major client.
Edison International NYSE: EIX) hit another 52-week low after selling $400M in bonds.
Horsehead Holdings (NASDAQ: ZINC) hit new lows as earnings failedto give any inspiration. Shares closed almost 5% under the prior rangeof $9.04 to $26.14. With this stock name we could think of two newnicknames for the company, but we’ll be nice.
Mirant (NYSE: MIR) Followed Edison to join the wall of shame again down 2% under prior 52-week lows.
Zoltek Technologies (NASDAQ: ZOLT) was a shocker of an earningsdisappointment with wind power under question. Shares fell to $15.52,well under the old $17.75 to $48.78 52-week range.

Jon C. Ogg
August 12, 2008

The 52-Week Low Club (C)(MBI)(RAD)

247wallst — Thu, 20 Dec 2007 16:03:44 +0000

Rite Aid Corporation (RAD) Ugly earnings. No turnaround here. Falls to $2.71 from 52-week high of $6.74.

MBIA (MBI) Concerns about CDOs being insured here. Falls to $18.84 from 52-week high of $76.02.

SLM (SLM) Still falling after comments about tough 2008 and possible dividend cut. Down to $19.84 from 52-week high of $58.

Altus Pharmaceuticals (ALTU) Partnership with Genentech (DNA) broken off. Sells off to $4.80 from 52-week high of $20.50.

Amicus Therapeutics (FOLD) Wall St. views new drug as less than competitive to current offerings. Shares drop to $9.20 from 52-week high of $18.22.

Array Biopharma (ARRY) Clinical trial fails. Drops to $7.81 from 52-week high of $14.59

Citigroup (C) Fresh concerns about mortgage risks. Drops to $29.34 from 52-week high of $57.

Douglas A. McIntyre

Pre-Market Stock News (December 20, 2007) (ACN, ATVI, ALTU, ARRY, ATHX, BSC, BX, CAKE, ECHO, INTU, FDX, MLHR, IDEV, LDK, LEG, LOCM, NKE, ORCL, PIR, RIMM, RAD, RUTH, SMOD, SCS, DEEP, TRB)

247wallst — Thu, 20 Dec 2007 08:02:20 +0000

This is not every bit of news on individual stocks but this is the major news affecting many shares in pre-market activity this Thursday morning:

Accenture (ACN) stock up 4% after posting $0.60 EPS vs. estimate of $0.56.
Activision (ATVI) again guided earnings higher.
Altus Pharmaceuticals (ALTU) traded down almost 20% after it reacquired ALTU-238 development and commercialization rights for North America from Genentech, an end to the development pact.
Array BioPharma (ARRY) traded down almost 20% after it announced initial results from a Phase II study comparing its monotherapy with temozolomide in the first-line treatment of advanced melanoma showed no apparent difference in efficacy for the primary endpoint.
Athersys (ATHX) and Angiotech announce authorization of Phase I stem cell trial for heart attacks.
Bear Stearns (BSC) expected to post first loss.
Blackstone (BX) plans to sell a $9 Billion CMBS offer backed by Hilton Hotels in Q1 2008.
Cheesecake Factory (CAKE) had a 10% stake taken by activist Nelson Peltz.
Electronic Clearing house (ECHO) getting acquired by intuit for $17.00 per share.
FedEx (FDX) $1.54 EPS vs. $1.50 estimates (had been lowered) but next quarter $1.15-1.30 vs. $1.38 est.; $6.40 to $6.70 for year bvs. $6.47 estimate.
Herman Miller (MLHR) $0.72EPS Vs. estimate of $0.59; stock rose about 10%.
Indevus Pharma (IDEV) trading down about 5% on a non-approvable letter from the FDA for VALSTAR NDA supplement (submitted May 2007).
Intuit (INTU) paying $131 Million for ECHO.
LDK Solar (LDK) $0.37 EPS on $157M revenues vs. $0.37/$143.22M est.; Q4 guidance $0.40-$0.41 on $180-$185M revenues vs. $0.41/$167.5M est.; stock indicated down 5%.
Leggett & Platt (LEG) stock down about 5% on lower guidance.
Local.com (LOCM) announced a strategic partnership with IAC/Interactive’s Citysearch; stock trading up 7% on news.
Nike (NKE) traded up 3% after $0.71 EPS on $4.3 Billion revenues vs. estimates $0.66/$4.3B.
Oracle (ORCL) traded up 6% after beating earnings and giving slightly higher guidance; sees enterprise spending lasting into 2008.
Pier 1 (PIR) -$0.11 EPS vs -$0.24 estimate.
Research-in-Motion (RIMM) reports earnings after the close today.
Rite Aid (RAD) indicated down about 5% after posting loss.
Ruths Chris (RUTH) gave an earnings warning.
Smart Modular Tech (SMOD) $0.18 EPS vs. $0.17 estimate.
Steelcase (SCS) $0.30 EPS vs. $0.28 estimate.
Superior Offshore (DEEP) signed a letter of intent with a strategic partner for ownership of a DP-III deepwater construction and dive support vessel expected to be delivered in late 2008.
Tribune (TRB) buyout supposedly set to close today.

Jon C. Ogg
December 20, 2007